Jie Ding

2.9k total citations
57 papers, 1.2k citations indexed

About

Jie Ding is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Jie Ding has authored 57 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 16 papers in Immunology and 14 papers in Oncology. Recurrent topics in Jie Ding's work include Renal Diseases and Glomerulopathies (10 papers), Epigenetics and DNA Methylation (9 papers) and Immune Cell Function and Interaction (5 papers). Jie Ding is often cited by papers focused on Renal Diseases and Glomerulopathies (10 papers), Epigenetics and DNA Methylation (9 papers) and Immune Cell Function and Interaction (5 papers). Jie Ding collaborates with scholars based in China, United States and Australia. Jie Ding's co-authors include Guoqing Liao, Oliver Groß, Judy Savige, Frances Flinter, Clifford E. Kashtan, Martin C. Gregory, Yi Zhang, Sheng Liu, Yu Zhang and Xia Yi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Jie Ding

55 papers receiving 1.2k citations

Peers

Jie Ding
Comparison fields: 5 of 89
  • Molecular Biology 604
  • Nephrology 214
  • Oncology 205
  • Immunology 197
  • Pulmonary and Respiratory Medicine 178
Replace Lai‐Fa Sheu with:
Lai‐Fa Sheu Taiwan
José G. van den Berg Netherlands
Masashi Haraguchi Japan
Sunfa Cheng United States
Tsukasa Takemura Japan
A Fukatsu Japan
M. Á. Aguirre Spain
Tatsuo Morita Japan
Marc Hilhorst Netherlands
L. Nakopoulou Greece
Lai‐Fa Sheu Taiwan View profile →
Citations per field, relative to Jie Ding
Jie Ding · 1×
Citations per year, relative to Jie Ding
Jie Ding · 1×

Countries citing papers authored by Jie Ding

Since Specialization
Citations

This map shows the geographic impact of Jie Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Ding more than expected).

Fields of papers citing papers by Jie Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jie Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Ding. The network helps show where Jie Ding may publish in the future.

Co-authorship network of co-authors of Jie Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Jie Ding. A scholar is included among the top collaborators of Jie Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie Ding. Jie Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 1
2 2
3 0
4 2
5 1
6 7
7 15
8 13
9 12
10 5
11 15
12 10
13 39
14 15
15 7
16 222
17 3
18 9
19
Anti-CD20 Monoclonal Antibody in Treatment of Refractory Nephrotic Syndrome
1
20 6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026